Culture

Digital Classics

Philadelphia’s life sciences market experienced a downturn over 2023, as the venture capital that was keeping it humming slowed to a trickle.

But a pair of new reports show that it hasn’t been hit as hard as other major biosciences hubs in the U.S., thanks to a slowdown in construction, and it could be poised for a comeback in the months ahead.